ScoreWhy is China Resources Boya Bio-pharmaceutical Group Co., Ltd. ?
1
Poor Management Efficiency with a low ROCE of 11.74%
- The company has been able to generate a Return on Capital Employed (avg) of 11.74% signifying low profitability per unit of total capital (equity and debt)
2
Poor long term growth as Net Sales has grown by an annual rate of -7.37% and Operating profit at -185.00% over the last 5 years
3
With a fall in Net Sales of -45.12%, the company declared Very Negative results in Mar 26
- The company has declared negative results for the last 4 consecutive quarters
- NET PROFIT(HY) At CNY -217.26 MM has Grown at -321.89%
- INTEREST(HY) At CNY 1.13 MM has Grown at 78.84%
- OPERATING CASH FLOW(Y) Lowest at CNY 36.21 MM
4
Below par performance in long term as well as near term
- Along with generating -42.21% returns in the last 1 year, the stock has also underperformed China Shanghai Composite in the last 3 years, 1 year and 3 months
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is China Resources Boya Bio-pharmaceutical Group Co., Ltd. for you?
Low Risk, Low Return
Absolute
Risk Adjusted
Volatility
China Resources Boya Bio-pharmaceutical Group Co., Ltd.
-42.22%
-2.36
22.59%
China Shanghai Composite
8.25%
1.20
14.07%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
-7.37%
EBIT Growth (5y)
-185.00%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.41
Sales to Capital Employed (avg)
0.26
Tax Ratio
100.00%
Dividend Payout Ratio
99.78%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
10.03%
ROE (avg)
4.93%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
0.96
EV to EBIT
-32.76
EV to EBITDA
-256.41
EV to Capital Employed
0.94
EV to Sales
2.49
PEG Ratio
NA
Dividend Yield
1.57%
ROCE (Latest)
-2.86%
ROE (Latest)
-0.48%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Bearish
Dow Theory
Mildly Bearish
No Trend
OBV
Mildly Bullish
Mildly Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend3What is working for the Company
PRE-TAX PROFIT(Q)
At CNY 29.28 MM has Grown at 166.76%
NET PROFIT(Q)
At CNY 24.61 MM has Grown at 69.49%
-32What is not working for the Company
NET PROFIT(HY)
At CNY -217.26 MM has Grown at -321.89%
INTEREST(HY)
At CNY 1.13 MM has Grown at 78.84%
OPERATING CASH FLOW(Y)
Lowest at CNY 36.21 MM
ROCE(HY)
Lowest at 0.05%
DEBT-EQUITY RATIO
(HY)
Highest at -34.15 %
RAW MATERIAL COST(Y)
Grown by 7.56% (YoY
INVENTORY TURNOVER RATIO(HY)
Lowest at 0.89 times
DEBTORS TURNOVER RATIO(HY)
Lowest at 2.25 times
NET SALES(Q)
Lowest at CNY 321.13 MM
Here's what is working for China Resources Boya Bio-pharmaceutical Group Co., Ltd.
Pre-Tax Profit
At CNY 29.28 MM has Grown at 166.76%
over average net sales of the previous four periods of CNY 10.98 MMMOJO Watch
Near term Pre-Tax Profit trend is very positive
Pre-Tax Profit (CNY MM)
Net Profit
At CNY 24.61 MM has Grown at 69.49%
over average net sales of the previous four periods of CNY 14.52 MMMOJO Watch
Near term Net Profit trend is positive
Net Profit (CNY MM)
Here's what is not working for China Resources Boya Bio-pharmaceutical Group Co., Ltd.
Interest
At CNY 1.13 MM has Grown at 78.84%
over previous Semi-Annual periodMOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (CNY MM)
Net Sales
At CNY 321.13 MM has Fallen at -37.62%
over average net sales of the previous four periods of CNY 514.77 MMMOJO Watch
Near term sales trend is extremely negative
Net Sales (CNY MM)
Operating Cash Flow
Lowest at CNY 36.21 MM and Fallen
In each year in the last three yearsMOJO Watch
The company's cash revenues from business operations are falling
Operating Cash Flows (CNY MM)
Debt-Equity Ratio
Highest at -34.15 % and Grown
In each half year in the last five Semi-Annual periodsMOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed
Debt-Equity Ratio
Net Sales
Lowest at CNY 321.13 MM
in the last five periodsMOJO Watch
Near term sales trend is negative
Net Sales (CNY MM)
Inventory Turnover Ratio
Lowest at 0.89 times
in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling inventory has slowed
Inventory Turnover Ratio
Debtors Turnover Ratio
Lowest at 2.25 times
in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling Debtors has slowed
Debtors Turnover Ratio
Raw Material Cost
Grown by 7.56% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin
Raw Material Cost as a percentage of Sales
Non Operating Income
Highest at CNY 0.47 MM
in the last five periodsMOJO Watch
Increased income from non business activities may not be sustainable
Non Operating income
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
